LTI-291

Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research.


Cat. No.: EX-A2518	Purity: >98%

	Chemical structure of LTI-291

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
500mg	650	In-stock
1g	1100	In-stock
5g	3800	In-stock
10g	get quote	In-stock
25g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Pariceract
Synonyms 2	BIA 28-6156
CAS No.	1919820-28-2
Purity	>98%
Formula	C20H30N4O2
Mol Weight	358.4778
Color	white to off-white
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>3 years if stored properly
Storage	Powder 4℃ 2 years; -20℃ 3 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1. [2]. Schneider SA, et al. J Neurol. 2020;267(3):860-869.
CoA	CoA of LTI-291

Smiles:	CCCCCO[C@H]1CC[C@@H](CC1)NC(=O)C1=C2N=C(C)C=C(C)N2N=C1


		Search